propofol |
9 |
analgesia |
6 |
general anesthesia |
6 |
postoperative pain |
6 |
acute postoperative pain |
5 |
general anaesthesia |
5 |
neuropathic pain |
5 |
pain |
5 |
total intravenous anesthesia |
5 |
acute |
4 |
adult population |
4 |
aging |
4 |
brg1 |
4 |
chronic pain |
4 |
colorectal surgery |
4 |
diabetes |
4 |
distal radial fracture fixation |
4 |
endothelin-1 |
4 |
inflammatory pain |
4 |
infraclavicular nerve block |
4 |
ischaemia/reperfusion injury |
4 |
isoflurane postconditioning |
4 |
myocardial ischemia injury |
4 |
nrf2 |
4 |
pkc-ε |
4 |
postoperative analgesia |
4 |
postoperative opioid consumption |
4 |
prevalence |
4 |
regional anesthesia |
4 |
repeated non-invasive limb ischemic preconditioning |
4 |
sevoflurane |
4 |
stat3 |
4 |
acute pain |
3 |
anaesthesia |
3 |
chronic post-ischaemic pain |
3 |
chronic regional pain syndrome |
3 |
complications |
3 |
endothelin type a receptor |
3 |
femoral neck fracture |
3 |
fractured hip |
3 |
fractured neck of femur |
3 |
il-6 |
3 |
laparoscopy |
3 |
laryngeal mask airway |
3 |
minimally invasive surgery |
3 |
n-methyl-d-aspartate receptors |
3 |
neuropathic |
3 |
nuclear factor of activated t-cells 5 |
3 |
nuclear factor-kappa b |
3 |
opioid requirements |
3 |
painpaired box gene 2 |
3 |
pathophysiological changes |
3 |
perioperative management |
3 |
pharmacogenetics |
3 |
pi3k |
3 |
polymorphisms |
3 |
postoperative |
3 |
pre-emptive |
3 |
preoperative assessment |
3 |
pten |
3 |
regional |
3 |
regional anaesthesia |
3 |
supraglottic airway device |
3 |
trendelenburg |
3 |
adverse effects |
2 |
analgesic activity |
2 |
animal cell |
2 |
animal experiment |
2 |
animal model |
2 |
anti-nociception |
2 |
cancer-related pain |
2 |
cannabinoids |
2 |
caudal epidural |
2 |
chronic non-cancer pain |
2 |
cohort analysis |
2 |
deleted in liver cancer 2 (dlc2) |
2 |
drug mechanism |
2 |
glutamate acid decarboxylases |
2 |
histone deacetylase 5 |
2 |
il-1β |
2 |
labor analgesia |
2 |
lumbar epidural |
2 |
meperidine |
2 |
meta-analysis |
2 |
meta-regression |
2 |
microgliap38 |
2 |
opioid |
2 |
opioids |
2 |
oral oxycodone |
2 |
osteogenesis imperfecta |
2 |
osteotomy surgery |
2 |
pain management |
2 |
patient care management |
2 |
patient-centred medical home care |
2 |
peripheral neuropathic pain |
2 |
pethidine |
2 |
pneumoperitoeum |
2 |
pneumoperitoneum |
2 |
rhoa rock |
2 |
spinal cord stimulation |
2 |
adrenergic agonists - pharmacology |
1 |
adrenergic alpha-1 receptor agonists |
1 |
adrenergic beta-1 receptor agonists |
1 |
adrenergic beta-antagonists - pharmacology |
1 |
androgen receptor |
1 |
animals |
1 |
caffeine - pharmacology |
1 |
caffeine-induced intracellular ca2+ concentration transients |
1 |
calcium radioisotopes |
1 |
calcium signaling - drug effects |
1 |
calcium-binding proteins - metabolism |
1 |
cells, cultured |
1 |
electric stimulation |
1 |
electrical-induced intracellular ca2+ concentration transients |
1 |
isoproterenol - pharmacology |
1 |
left ventricular developed pressure |
1 |
male |
1 |
myocardial contraction - drug effects |
1 |
myocardium - enzymology - metabolism |
1 |
na+/ca2+ exchanger |
1 |
norepinephrine - pharmacology |
1 |
orchiectomy |
1 |
phenylephrine - pharmacology |
1 |
propanolamines - pharmacology |
1 |
rats |
1 |
rats, sprague-dawley |
1 |
receptors, adrenergic, alpha-1 - metabolism |
1 |
receptors, adrenergic, beta-1 - metabolism |
1 |
receptors, androgen - metabolism |
1 |
ryanodine receptor |
1 |
ryanodine receptor calcium release channel - metabolism |
1 |
sarco(endo)plasmic reticulum ca 2+-atpase |
1 |
sarcoplasmic reticulum calcium-transporting atpases - metabolism |
1 |
sodium-calcium exchanger - metabolism |
1 |
testosterone - administration & dosage - metabolism |
1 |
time factors |
1 |
velocity of contraction and relaxation |
1 |
ventricular function, left - drug effects |
1 |
ventricular pressure - drug effects |
1 |